High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma

BACKGROUND: Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is the first rate-limiting enzyme of the hexosamine biosynthesis pathway (HBP), which plays a pivotal role in the progression of pancreatic ductal adenocarcinoma (PDAC). Therefore, we investigated the prognostic significance of GFPT1...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Yitao, Qian, Yunzhen, Luo, Guopei, Liu, Yu, Wang, Ruijie, Deng, Shengming, Cheng, He, Jin, Kaizhou, Ni, Quanxing, Yu, Xianjun, Wu, Weiding, Liu, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849098/
https://www.ncbi.nlm.nih.gov/pubmed/33517899
http://dx.doi.org/10.1186/s12957-021-02147-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849098/
https://www.ncbi.nlm.nih.gov/pubmed/33517899
http://dx.doi.org/10.1186/s12957-021-02147-z

Ejemplares similares